Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy
| Filename | 417. Liao et al., Oma CSU pregnancy, Front.Immunol2021.pdf |
| Filesize | 282,34 kB |
| Version | o.417 |
| Date added | Mai 31, 2021 |
| Downloaded | 0 times |
| Category | Original Work |
| Tags | angioedema, chronic spontaneous urticaria, omalizumab, Pregnancy, Wheals |
| Authors | Liao, S. L., Yu, M., Zhao, Z., and Maurer, M. |
| Citation | Liao, S. L., Yu, M., Zhao, Z., and Maurer, M.: Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy. Front. Immunol. 2021: 12; 652973. |
| Corresponding authors | Maurer, M. |
| DocNum | o.417 |
| DocType | |
| Equivalent authors | Zhao, Z., and Maurer, M. |
| IF | 8.79 |
| Publisher | Front. Immunol. |
| ReleaseDate | 2021 |
Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patients treated with omalizumab and review the published information on omalizumab treatment during 11 pregnancies. The outcomes reported on patients with known pregnancies showed they had normal pregnancies and healthy babies as well as complete control of their CSU. The two new cases we reported support the view that omalizumab could be an effective and safe treatment option for pregnant and breastfeeding CSU patients. Further high-quality studies need to be carried out in order to obtain more information on the longterm efficacy and safety of the use of omalizumab during pregnancy in patients with chronic urticaria, including CSU.
(Last update: 12.2023)
| Number of original publications in peer-reviewed journals: | 580 |
| Number of reviews in peer-reviewed journals: | 210 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
| Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
| Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
| Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.